The rise of Viagra initially sparked a surge for major pharmaceutical companies, but recent developments present a complicated scenario for shareholders. Generic competitors are reducing earnings, and continued patent https://henrimjhu297389.blogacep.com/46803399/sildenafil-and-pharma-a-precarious-bet